Article
Ruthenium plaque brachytherapy in vasoproliferative tumors of the retina
Search Medline for
Authors
Published: | September 21, 2010 |
---|
Outline
Text
Introduction: Vasoproliferative tumors of the retina are lesions of unknown origin, developing with or without association to other intraocular findings. These benign lesions may reduce vision by complications like maculopathy, retinal detachment and central subretinal lipid deposition.
Methods: Retrospective interventional case series.
Results: 16 eyes in 16 pts were treated between 2001 and 2008 using Ruthenium Brachytherapy. VA was median 0.4 before and median 0,5 after therapy.Tumor height was 2.9 mm (mean) before and 1.6 mm (mean) after treatment. 5 patients received additional vitrektomy.
Conclusion: Brachytherapy may be useful in inducing regression of Vasoproliferative tumors of the retina but additional treatment seems to be reasonable in a significant number of patients.